Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of PharmaBXL is 1.7% (average). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
3 mandates
2
active directors
PharmaLegalManaging directorREMEDIADirector+1 in history
All directors & mandates Publicationslatest 31-03-2026
9
publications in the State Gazette1 director appointed, 1 resigningAll publications & acts Network & structure
3
connected companiesSee network & structure
Connections
3 connected companiesParent · 1 subsidiary · 1 location
Control→
Parent · 2 subsidiaries · 1 location
Control→
Trust signals
3 signalsMore than 3 years active
Founded in 2022 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.7%
Average
0%0,5%1,5%4%10%≥25%
Young company
+Higher-failure-rate region
+Lower-failure-rate sector
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Apotheken47730Detailhandel in farmaceutische producten47730Overige zakelijke dienstverlening, neg82990Groothandel in parfumerieën en cosmetica46450Groothandel in parfumerieën en cosmetica46450Holdings64200Activiteiten van holdings64210
Primary activity highlighted.
Names & trade names
| Legal nameNL | PharmaBXL |
Registered office
Zavelput 17
1000 Brussel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.